Clinical Trial Update: The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemoimmunotherapy combined with node-sparing radiotherapy for cT3N+ esophageal cancer (stage III). The study status is not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Esophageal Cancer Stage III | Phase 2 | Status: NOT_YET_RECRUITING